KATIE O'HALLORAN: Open Payments
NPI 1104427293 · MATTOON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 31 payments from 10 companies in 2025. Trend: 2023 $1,171 · 2024 $553 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $218 |
| Merck Sharp & Dohme LLC | 5 | $139 |
| Amgen Inc. | 5 | $104 |
| Boston Scientific Corporation | 3 | $86 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $57 |
| Kestra Medical Technology Services, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Medtronic, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
Products named: LEQVIO, VERQUVO, REPATHA, WATCHMAN Access System, LifeVest, Assure WCD, JARDIANCE, MICRA.
Industry payments across IL — which companies pay providers there.
